Last update April 18, 2022

Hydrocortisone, Topical Use (dermatological, ophthalmic, otic, intestinal enema)

Very Low Risk

Safe. Compatible. Minimal risk for breastfeeding and infant.

Hydrocortisone or cortisol is a natural steroid produced in the adrenal cortex. It has glucocorticoid and, to a lesser extent, mineralocorticoid effects. Its esters are used as topical anti-inflammatories (dermatological, intestinal, ophthalmic and otic).

At the date of the last update we did not find any published data on its excretion in breast milk.

Topical use: The poor absorption through the skin and conjunctiva makes it unlikely that a significant amount will pass into breast milk. Bioavailability through the skin is less than 20% and after retention enema from 50 to 80%. (DrugBank acces.2022) 

Furthermore, its pharmacokinetic data (high percentage of protein binding, wide volume of distribution and short half-life) make it highly unlikely that significant quantities will pass into breast milk.

Whenever a treatment for nipple eczema or dermatitis is required, it should be applied right after the feed to make sure it has disappeared before the next nursing occurs. Otherwise, wipe cream out with a clean gauze. Do not continuously use for longer than a week.

Reportedly, a case of mineral-steroid toxicity has occurred due to continuous use of cream on the nipple. (De Stefano 1983)

Creams, gels or similar products that contain paraffin or mineral oil should not be used on the nipple to avoid absorption by the infant. (Concin 2008, Noti 2003)

Eleventh WHO Model List of Essential Drugs 2002: topical use compatible with breastfeeding. (WHO 2002)


See below the information of this related product:

Alternatives

We do not have alternatives for Hydrocortisone, Topical Use (dermatological, ophthalmic, otic, intestinal enema) since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Hydrocortisone, Topical Use (dermatological, ophthalmic, otic, intestinal enema) is also known as


Hydrocortisone, Topical Use (dermatological, ophthalmic, otic, intestinal enema) in other languages or writings:

Tradenames

Main tradenames from several countries containing Hydrocortisone, Topical Use (dermatological, ophthalmic, otic, intestinal enema) in its composition:

  • Aquacort
  • Ciproxina™. Contains other elements than Hydrocortisone, Topical Use (dermatological, ophthalmic, otic, intestinal enema) in its composition
  • Cohortan™. Contains other elements than Hydrocortisone, Topical Use (dermatological, ophthalmic, otic, intestinal enema) in its composition
  • Cortisporin Ointment™. Contains other elements than Hydrocortisone, Topical Use (dermatological, ophthalmic, otic, intestinal enema) in its composition
  • Cristalomicina™. Contains other elements than Hydrocortisone, Topical Use (dermatological, ophthalmic, otic, intestinal enema) in its composition
  • Dermo Hubber™. Contains other elements than Hydrocortisone, Topical Use (dermatological, ophthalmic, otic, intestinal enema) in its composition
  • Hemorrane™. Contains other elements than Hydrocortisone, Topical Use (dermatological, ophthalmic, otic, intestinal enema) in its composition
  • Isdinium
  • Kinogen (Italy)™. Contains other elements than Hydrocortisone, Topical Use (dermatological, ophthalmic, otic, intestinal enema) in its composition
  • Lactisona
  • Oralsone adultos
  • Proctol™. Contains other elements than Hydrocortisone, Topical Use (dermatological, ophthalmic, otic, intestinal enema) in its composition
  • Proctomyxin HC™. Contains other elements than Hydrocortisone, Topical Use (dermatological, ophthalmic, otic, intestinal enema) in its composition
  • Proctosedyl™. Contains other elements than Hydrocortisone, Topical Use (dermatological, ophthalmic, otic, intestinal enema) in its composition
  • Proktosedon™. Contains other elements than Hydrocortisone, Topical Use (dermatological, ophthalmic, otic, intestinal enema) in its composition
  • Shericur
  • Suniderma
  • Uniroid-HC™. Contains other elements than Hydrocortisone, Topical Use (dermatological, ophthalmic, otic, intestinal enema) in its composition
  • Westcort
  • ratio-Proctosone™. Contains other elements than Hydrocortisone, Topical Use (dermatological, ophthalmic, otic, intestinal enema) in its composition

Pharmacokinetics

Variable Value Unit
Oral Bioavail. Dermat: 4 - 19 enema: 50 - 80 %
Molecular weight 363 daltons
Protein Binding 90 %
VD 0.48 - 1 l/Kg
pKa 12.59 -
Tmax 1 hours
1 - 2 hours

References

  1. DRUGBANK ONLINE. DrugBank.com 2006 - Consulted on April 18, 2022 Full text (link to original source)
  2. AEMPS. Hidrocortisona tópica. Ficha técnica. 2010 Full text (link to original source) Full text (in our servers)
  3. Concin N, Hofstetter G, Plattner B, Tomovski C, Fiselier K, Gerritzen K, Fessler S, Windbichler G, Zeimet A, Ulmer H, Siegl H, Rieger K, Concin H, Grob K. Mineral oil paraffins in human body fat and milk. Food Chem Toxicol. 2008 Abstract
  4. Noti A, Grob K, Biedermann M, Deiss U, Brüschweiler BJ. Exposure of babies to C15-C45 mineral paraffins from human milk and breast salves. Regul Toxicol Pharmacol. 2003 Abstract
  5. WHO / UNICEF. BREASTFEEDING AND MATERNAL MEDICATION Recommendations for Drugs in the Eleventh WHO Model List of Essential Drugs. Department of Child and Adolescent Health and Development (WHO/UNICEF) 2002 Full text (link to original source) Full text (in our servers)
  6. Nice FJ, Snyder JL, Kotansky BC. Breastfeeding and over-the-counter medications. J Hum Lact. 2000 Nov;16(4):319-31. Review. Erratum in: J Hum Lact 2001 Feb;17(1):90. Abstract
  7. De Stefano P, Bongo IG, Borgna-Pignatti C, Severi F. Factitious hypertension with mineralocorticoid excess in an infant. Helv Paediatr Acta. 1983 Abstract

Total visits

64,148

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM